Litfulo 50 mg hard capsules

Licence status
Authorised: 15/09/2023
Active substances
Ritlecitinib
Dosage Form
Capsule, hard
Licence number
EU/1/23/1755/001-003
Licence holder
Pfizer Europe MA EEIG

Product documents

Licence information

ATC code
L04AA Selective immunosuppressants, L04AF08 Ritlecitinib
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
15/09/2023